Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based cancer therapy. Helper T cells act as the immune system’s coordinators, helping ...

For pathogens like HIV, malaria, and rapidly evolving influenza strains, coaxing the immune system to produce the rare, highly potent antibodies needed for protection has long been a scientific ...

Astellas is preparing to close its Seattle site for its stem cell therapy unit, with around 55 employees set to be affected. The Japanese pharma acquired the site when it bought Seattle-based ...

Forbes contributors publish independent expert analyses and insights. Rachel Wells is a writer who covers leadership, AI, and upskilling. Ever wondered how some freelancers are able to make money ...

Red blood cells modified with Nobel-prizewinning chemistry can snap together to form clots that staunch bleeding in seconds.

A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke Koike Supported by By Susan Dominus Why are babies born young? The most ...

Energy can never be created or destroyed. That's basic Physics 101. You simply cannot create energy out of thin air. Yet researchers at Kyushu University in Japan say they have developed a technology ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

David Pogue is a six-time Emmy winner for his stories on "CBS Sunday Morning," where he's been a correspondent since 2002. Pogue hosts the CBS News podcast "Unsung Science." He's also a New York Times ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...